Atlas Trials

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Clinical trial NCT00189488 · COMPLETED

Trial details

NCT number
NCT00189488
Sponsor
Swedish Orphan Biovitrum
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host DiseaseHematologic Malignancies
Start date
2005-12-01
Primary completion
2008-11-01
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.